Fallopian Tube Cancer Clinical Trials 
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.Huaier Granule in Patients With Stage I Primary Ovarian Fallopian Tube Cancer After Peritoneal Cancer
Conditions: Primary Ovarian Cancer; Fallopian Tube Cancer; Peritoneal Cancer Intervention: Drug: Huaier granule Sponsor: Ruijin Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 31, 2023 Category: Research Source Type: clinical trials
A Phase II Study Evaluating the Effect of GEN-1 on SLL When Administered in Combination With Bevacizumab and NACT in Subjects Newly Diagnosed With Advanced Ovarian, Fallopian Tube or Primary Peritoneal Cancer
Conditions: Ovarian Cancer; Fallopian Tube Cancer; Primary Peritoneal Cancer Interventions: Drug: Paclitaxel; Drug: Carboplatin; Drug: Bevacizumab; Drug: GEN1 Sponsors: Imunon; Break Through Cancer Foundation Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 22, 2023 Category: Research Source Type: clinical trials
